Marquette county health department
Dickinson-Iron District Health Department
818 Pyle Dr., Kingsford, MI 49802
601 Washington Ave., Iron River, MI 49935
LINDA PIPER, RN, BSN, MPH
TERESA FRANKOVICH, MD, MPH
H1N1 (Swine) Influenza
Uncomplicated Gonococcal Infections of the Cervix, Urethra
Upper Peninsula Reportable Communicable Diseases
Note from the Medical Director
During this spring’s H1N1 outbreak (see below), the health department strived to ensure that
clinicians were linked to CDC and MDCH guidance on testing and treatment/ prophylaxis. Fax
distributions and emails, as well as the health department website were utilized. Please let me
know if you did not receive needed information or if you have ideas on how to most effectively
reach clinicians. Call me at 906-482-7382 x 112 or em.
H1N1 (Swine) Influenza
It has now been nearly three months since the CDC first linked cases of a new flu strain, “Swine”
or “H1N1”, in two California children, living in adjacent counties. This identification sparked a
national response to an emerging novel flu strain. Recently, the World Health Organization
raised the Pandemic Flu level to “6”. Rather than reflecting the severity of the circulating flu,
this designation simply addresses the spread of the virus. The virus has now reached a point
where it is present in over 100 countries world-wide and is being transmitted at a community
level in more than one region of the world. Setting the level at “6” is a signal to all countries to
look at their pandemic flu plans and revise them as needed. Currently H1N1 is making up ~99%
of sub-typed influenza A viruses analyzed by U.S. WHO/NREVSS laboratories.
In the United States, there have now been over 34,000 confirmed cases of H1N1 flu with an
estimate of over 1 million actual cases. In Michigan there have been over 1,000 confirmed cases
with only a few confirmed cases reported in the U.P. (Chippewa, Marquette, Delta, Houghton,
Luce). Although there have been 170 deaths nationally and 7 in Michigan (Roscommon,
Oakland, Wayne and Macomb Counties), the vast majority of individuals who develop H1N1 flu
have only mild symptoms and recover fully without hospitalization. Although nationally, the
number of individuals with influenza-like illness has been declining (although still above normal
for this time of year), some areas of the country are continuing to have significant outbreaks.
The largest number of cases are still occurring in patients young, healthy individuals. Older
adults appear to have some degree of immunity, presumably from past exposure to a similar
strain. Approximately 3/4 of the individuals hospitalized or dying from H1N1, have underlying
conditions such as respiratory disease, cardiac disease, diabetes, obesity, immune compromise
and pregnancy. Only 6% of hospitalized patients are over 65 years at last report.
It is still unclear what this virus will bring over time. As H1N1 circulates among the usual flu
viruses over the coming months in the southern hemisphere, the CDC will be watching to see
how the virulence, anti-viral susceptibility and at-risk groups change.
A two-dose vaccine will likely be available this fall. Decisions about priority groups for
vaccinating will help guide plans for H1N1 flu clinics. If you would like more information about STD Management
Chlamydia and gonorrhea are reportable diseases and are included in the Communicable Disease
Summary below. Of note, gonorrhea has resurfaced in some western U.P. communities.
Although the numbers are not large (~9 cases in Dickinson-Iron Counties this past year), it is
important to consider GC in the differential when seeing individuals with STD symptoms.
Treatment guidance from the CDC is as follows. Please note that the fluoroquinolones are no
longer recommended for treatment of GC, due to acquired resistance.
Uncomplicated Gonococcal Infections of the Cervix, Urethra, and Rectum*
Recommended Regimens Ceftriaxone
125 mg IM in a single dose OR Cefixime
400 mg orally in a single dose or 400 mg by suspension (200 mg/5ml) PLUS
TREATMENT FOR CHLAMYDIA IF CHLAMYDIAL INFECTION IS NOT RULED OUT
* These regimens are recommended for all adult and adolescent patients, regardless of travel
history or sexual behavior.
Alternative Regimens Spectinomycin†
2 g in a single intramuscular (IM) dose OR Single-dose cephalosporin regimens
† Spectinomycin is currently not available in the United States.
Other single-dose cephalosporin therapies that are considered alternative treatment regimens for
uncomplicated urogenital and anorectal gonococcal infections include ceftizoxime 500 mg IM;
or cefoxitin 2 g IM, administered with probenecid 1 g orally; or cefotaxime 500 mg IM. Some
evidence indicates that cefpodoxime 400 mg and cefuroxime axetil 1 g might be oral
Chlamydia Urogenital Infection
Recommended Regimens Azithromycin
1 g orally in a single dose OR Doxycycline
100 mg orally twice a day for 7 days Alternative Regimens Erythromycin base
500 mg orally four times a day for 7 days OR Erythromycin ethylsuccinate
800 mg orally four times a day for 7 days OR Ofloxacin
300 mg orally twice a day for 7 days OR Levofloxacin
500 mg orally once daily for 7 days
Medical Marijuana in Michigan
The Michigan Medical Marihuana Program (MMMP) is a state registry program within the
Bureau of Health Professions at the Michigan Department of Community Health and is currently
operational. Details about the program rules and the physician role in assisting patients in
obtaining medical marijuana may be found at:
Physicians will not be providing prescriptions to patients but may be asked by their patients to sign a certificate (may be downloaded from the MDCH website), which essentially states that the patient has a qualifying condition which may reasonably be expected to benefit from medical marijuana. The certificate must be signed by an M.D. or D.O., who is a healthcare provider for the patient. Physicians may also choose not to sign certificates.
Local public health departments will have no role in implementing or overseeing this program and will be referring callers to the MDCH website.
Upper Peninsula Reportable Communicable Diseases
May/June 2009 and YTD
Region 8 Communicable Disease Summary
May 1st, 2009 through June 30th, 2009
Notes: Flu-like Disease category contains cases of unconfirmed illness reported from schools Summary includes cases under active investigation at the time the report was created
Marquette Western UP
Period YTD Period YTD Period
YTD Period YTD Period YTD Period YTD Period YTD
fraternus Webster) BINAY SEN * Institute of Medical Sciences, Banaras Hindu University, Varanasi- 5 (U. P.). ABSTRACT : Tamakashvâsa as described in Âyurveda is a disease of Prânavaha Srotas (Respiratory system) involving multiple etiopathogenesis. The clinical features are nearly similar to that of Bronchial asthma described in Modern medicine. This study was designed to explore th
Review of Sociology Vol. 9 (2003) 2. 151–159 THE NETWORK SAGA* Budapest University of Economic Sciences and Public AdministrationBudapest, Fõvám tér 8. H-1093; e-mail: email@example.comBarabási, Albert-László: Linked. The New Science of Networks. Cambridge MA: PerseusA Hungarian sociologist has two good reasons to be proud nowadays. First, as a Hungarian, since on the other side of th